PCR
Simplify VettaFi Private Credit Strategy ETF
$19.11
$-0.02 (-0.10%)
Delayed ≥20 min · Sep 3, 2026
Key Statistics
Net Assets (AUM)
$2.39M
Expense Ratio
See prospectus
Previous Close
$19.13
Day Range
$19.11 – $19.11
52-Week Range
$18.59 – $25.37
Volume
36
Avg Vol (50D)
-
Beta
-1.43
Historical Performance
1M
+1.35%
3M
+0.95%
6M
+1.91%
YTD
-10.37%
1Y
-23.56%
3Y
—
5Y
—
Total return including reinvested distributions, from adjusted closing prices.
Price History
Price history is being compiled for this fund.
Top Holdings
Detailed holdings are compiled from each fund’s latest SEC N-PORT portfolio filing.
About PCR
Simplify VettaFi Private Credit Strategy ETF
PCR News
- Qiagen (QGEN) Up 5.1% Since Last Earnings Report: Can It Continue?
- Net Asset Value Restatement for Simplify VettaFi Private Credit Strategy ETF (PCR)
- Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
- EverGen Infrastructure Corp (EVGIF) (Q2 2026) Earnings Call Highlights: Revenue Surges 71% and ...
- Amcor supplies Tiptree with certified 30% PCR films
- Qiagen (QGEN) Beat Its Own Guidance, So Why Did Margins Slip?
- Qiagen (QGEN) Beat Its Own Guidance, So Why Did Margins Slip?
- Co-Diagnostics files FDA 510(k) for flu and RSV PCR test
- Where Walmart’s packaging ended up on 2025 sustainability targets
- Bio-Rad Laboratories Inc (BIO) (Q2 2026) Earnings Call Highlights: Digital PCR Surges 20%+ as ...
- Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform
- Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform
Data for PCR is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.